Dosidal · Switzerland

Bilastin-Mepha Allergie lingual, Schmelztabletten

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69558 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69558
atc: R06AX29
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-03-16
term: zugelassen
valid_until: 2030-03-15
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: R06AX29
authorisation_number: 69558
form: SCHM
holder: Mepha Pharma AG
holder_partner_nr: 1006155
it_number: 07.13.1.
name: Bilastin-Mepha Allergie lingual, Schmelztabletten
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
pNVojMa7p-pR-wzJJvU9zVPKKsJSxmA1xQQsDZ4KCRsXIe7nAUfpRPqXe6Inwzh-MpRKTVKuYSaWWqW1FpDiNw
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69558 · Related records in other markets · Dosidal